- Home
- AGD vs SOPH Comparison
AGD vs SOPH Comparison
Compare AGD & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGD
- SOPH
- Stock Information
- Founded
- AGD 2006
- SOPH 2011
- Country
- AGD United Kingdom
- SOPH Switzerland
- Employees
- AGD N/A
- SOPH N/A
- Industry
- AGD Trusts Except Educational Religious and Charitable
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AGD Finance
- SOPH Health Care
- Exchange
- AGD Nasdaq
- SOPH Nasdaq
- Market Cap
- AGD 263.6M
- SOPH 219.8M
- IPO Year
- AGD N/A
- SOPH 2021
- Fundamental
- Price
- AGD $11.24
- SOPH $3.46
- Analyst Decision
- AGD
- SOPH Buy
- Analyst Count
- AGD 0
- SOPH 1
- Target Price
- AGD N/A
- SOPH $7.00
- AVG Volume (30 Days)
- AGD 61.2K
- SOPH 152.3K
- Earning Date
- AGD 01-01-0001
- SOPH 08-05-2025
- Dividend Yield
- AGD 8.13%
- SOPH N/A
- EPS Growth
- AGD N/A
- SOPH N/A
- EPS
- AGD N/A
- SOPH N/A
- Revenue
- AGD N/A
- SOPH $67,173,000.00
- Revenue This Year
- AGD N/A
- SOPH $16.07
- Revenue Next Year
- AGD N/A
- SOPH $22.94
- P/E Ratio
- AGD N/A
- SOPH N/A
- Revenue Growth
- AGD N/A
- SOPH 4.66
- 52 Week Low
- AGD $8.20
- SOPH $2.58
- 52 Week High
- AGD $9.78
- SOPH $4.92
- Technical
- Relative Strength Index (RSI)
- AGD 71.70
- SOPH 58.47
- Support Level
- AGD $11.15
- SOPH $2.81
- Resistance Level
- AGD $11.25
- SOPH $3.79
- Average True Range (ATR)
- AGD 0.10
- SOPH 0.27
- MACD
- AGD 0.01
- SOPH 0.05
- Stochastic Oscillator
- AGD 98.77
- SOPH 66.33
About AGD abrdn Global Dynamic Dividend Fund of Beneficial Interest
Aberdeen Global Dynamic Dividend Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to seek high current dividend income, more than 50% of which qualifies for the reduced federal income tax rate, as created by the Jobs and Growth Tax Relief Reconciliation Act of 2003. The fund also focuses on the long-term growth of capital as a secondary investment objective. The fund's portfolio holdings are in information technology, financials, health care, and consumer discretionary sectors among others.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.